JOHN CRAIG THOMPSON

CIK 1509643 · President & CEO · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$251.6K

Companies

4

Total Filings

24

Lifetime Open-Market Net

-$3.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ESPR Director 79,873 $3.15 $251.6K $0 2 2026-06-01
Anthera Pharmaceuticals Inc (ANTH) Delisted President & CEO 19,848 $26.2K 9 2018-01-09
TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted Chief Operating Officer 10,343 -$3.96M 8 2015-09-10
Trius Therapeutics Inc (TSRX) Delisted Chief Commercial Officer 133 $862 4 2013-03-11

Recent Filings · Page 3 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-03-11 Trius Therapeutics Inc (TSRX) Delisted Grant (A) $0 EDGAR
2012-03-12 Trius Therapeutics Inc (TSRX) Delisted Grant (A) $0 EDGAR
2011-08-24 Trius Therapeutics Inc (TSRX) Delisted Buy (P) +133 $862 EDGAR
2011-01-11 Trius Therapeutics Inc (TSRX) Delisted Grant (A) $0 EDGAR
Showing 2124 of 24
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.